Description
An MT2 receptor agonist (Ki = 1.12 nM); is 5.2-fold selective for MT2 over MT1 receptors in a radioligand binding assay; striatal microinfusion increases the percentage of time spent in the open arms of the elevated plus maze in a rat model of rotenone-induced Parkinson’s disease at 10 μg/μl
Formal name: N-(1,2,3,4-tetrahydro-8-methoxy-2-naphthalenyl)-propanamide
Synonyms: AH 002
Molecular weight: 233.3
CAS: 134865-70-6
Purity: ≥98%
Formulation: A crystalline solid